Venus Remedies hit upper circuit after company gets marketing nod for six chemotherapy drugs

Lupin share jumps 3% on launching anesthesia injection in US

Venus Remedies has received the marketing approval from the Philippines, the second largest market in the Association of Southeast Asian Nations (ASEAN) bloc, for six key chemotherapy drugs. Venus Remedies has secured the marketing authorisation for bortezomib cisplatin, doxorubicin, docetaxel, flurouracil and paclitaxel. With this, the pharma company has secured 525 marketing approvals for its … Read more